Vaxxas secures funding interest to see if professor Fraser utilizes nanopatch, page-74

Your point was on your 1st post that they would need a CR to fund phase 2a
But my point if you click in the lick was more than clear, They have already paid for the phase 2a study. You cannot unwind it. We pay for it in 1 of 2 ways.
We pay for a bigger stake in the Vax which means all of then not just one as part payment, and we also pay QU for the trail so they can go ahead with it.
its good for both them and us as we have over the years gone from holding 21% to 66% without holding a larger %age what would any deal have do that would have been a benefit to Admedus without adding more %age along the way